510(k) Report

510(k) · Cleared

Cleared

Modification to TSRH Spinal System

K014076510(k) SpecialCleared Dec 27, 200116-day reviewClass II21 CFR 888.3070

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Medtronic Sofamor Danek, Inc. · MNH Orthosis, Spondylolisthesis Spinal Fixation

Cleared on Dec 27, 2001 after a 16-day review. The FDA summary names its predicate without a number. 38 later devices descend from it.

Decided
Dec 27, 2001
Review
16 days
Class
Class II
Product code
MNH
Recalls
None
Predicates
0

38 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2002: 1 descendant cleared2011: 1 descendant cleared2012: 1 descendant cleared2015: 4 descendants cleared2013: 1 descendant cleared2014: 4 descendants cleared2017: 2 descendants cleared2024: 7 descendants cleared2020: 1 descendant cleared2016: 3 descendants cleared2026: 2 descendants cleared2022: 2 descendants cleared2023: 3 descendants cleared2018: 5 descendants cleared2021: 1 descendant cleared200020052010201520202025
  1. This deviceK014076 Modification to TSRH Spinal SystemMedtronic Sofamor Danek, Inc. · 2001
  2. Descendant · cites it directly · 37 of its ownK021106 Modification to TSRH Spinal SystemMedtronic Sofamor Danek, Inc. · 2002
  3. Descendant · 2 generations on · 36 of its ownK110676 TSRH Spinal SystemMedtronic Sofamor Danek · 2011
  4. Descendant · 3 generations on · 35 of its ownK120899 Range Spinal System, Unit RodK2m, Inc. · 2012
  5. Descendant · 4 generations on · 34 of its ownK131030 Range Spinal SystemK2m, Inc. · 2013
  6. Descendant · 5 generations on · 33 of its ownK133944 Range, Spinal System, Everest Spinal SystemK2m, Inc. · 2014

Showing 5 of 38 descendants. See all descendants

Descendants cleared per year

2002: 12011: 12012: 12013: 12014: 42015: 42016: 32017: 22018: 52020: 12021: 12022: 22023: 32024: 72026: 2
2002high 7 (2024) · low 0 (2003)2026

Most influential descendants

Showing 5 of 38 · See all
  • K021106Modification to TSRH Spinal SystemMedtronic Sofamor Danek, Inc. · 2002 · cites it directly37descendants
  • K110676TSRH Spinal SystemMedtronic Sofamor Danek · 2011 · 2 generations on36descendants
  • K120899Range Spinal System, Unit RodK2m, Inc. · 2012 · 3 generations on35descendants
  • K131030Range Spinal SystemK2m, Inc. · 2013 · 4 generations on34descendants
  • K133944Range, Spinal System, Everest Spinal SystemK2m, Inc. · 2014 · 5 generations on33descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K014076Modification to TSRH Spinal SystemMedtronic Sofamor Danek, Inc.2001—
+1K021106Modification to TSRH Spinal SystemMedtronic Sofamor Danek, Inc.2002—
+2K110676TSRH Spinal SystemMedtronic Sofamor Danek2011—
+3K120899Range Spinal System, Unit RodK2m, Inc.2012—
+4K131030Range Spinal SystemK2m, Inc.2013—
+5K133944Range, Spinal System, Everest Spinal SystemK2m, Inc.2014—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200210
201110
201210
201310
201440
201540
201630
201720
201850
202010
202110
202220
202330
202470
202620
FIG. 1 — Lineage of K014076, 2001–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MNH? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—TSRH® Spinal System
Named without a submission number
—

What descends from it? (38)

See all 38

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K021106Modification to TSRH Spinal SystemMedtronic Sofamor Danek, Inc.200237

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K021106 (Medtronic Sofamor Danek, Inc., 2002) has gone furthest, with 37 descendants of its own.

How does its category compare?

All MNH devices

MNH Orthosis, Spondylolisthesis Spinal Fixation: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · MNH

8in 2016

2007: 52008: 132009: 132010: 102011: 172012: 72013: 102014: 122015: 102016: 8
2007high 17 (2011) · low 0 (2017)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MNH

93in 2016

2007: 123 days median2008: 65 days median2009: 151 days median2010: 106 days median2011: 171 days median2012: 93 days median2013: 124 days median2014: 140 days median2015: 99 days median2016: 93 days median
2007high 171 (2011) · low 65 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MNH

1in 2016

2009: 72012: 12013: 12016: 1
2007high 7 (2009) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MNH

89in 2025

2007: 182008: 302009: 452010: 592011: 1072012: 4332013: 4642014: 2862015: 1522016: 2162017: 1742018: 1292019: 4032020: 4322021: 5312022: 2652023: 1212024: 3022025: 89
2007high 531 (2021) · low 18 (2007)2025

MAUDE reports naming product code MNH, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20075123018
20081365030
200913151745
201010106059
2011171710107
20127931433
2013101241464
2014121400286
201510990152
20168931216
20170—0174
20180—0129
20190—0403
20200—0432
20210—0531
20220—0265
20230—0121
20240—0302
20250—089
20260—0—

What is it indicated for?

When used as a pedicle screw fixation system of the non-cervical posterior spine in skeletally mature patients, the TSRH® Spinal System is indicated for one or more of the following: (1) degenerative spondylolisthesis with objective evidence of neurologic itnpairment, (2) fracture, (3) dislocation, (4) scoliosis, (5) kyphosis, (6) spinal tumor, and/or (7) failed previous fusion (pseudarthrosis). In addition, when used as a pedicle screw fixation system…

Read the full statement (271 words)

When used as a pedicle screw fixation system of the non-cervical posterior spine in skeletally mature patients, the TSRH® Spinal System is indicated for one or more of the following: (1) degenerative spondylolisthesis with objective evidence of neurologic itnpairment, (2) fracture, (3) dislocation, (4) scoliosis, (5) kyphosis, (6) spinal tumor, and/or (7) failed previous fusion (pseudarthrosis).

In addition, when used as a pedicle screw fixation system, the TSRH® Spinal System is indicated for skeletally mature patients: (a) having severe spondylolisthesis (Grades 3 and 4) of the fifth lumbar-first sacral (L5-S1) vertebral joint; (b) who are receiving fusions using autogenous bone graft only; (c) who are having the device fixed or attached to the lumbar and sacral spine (L3 and below); and (4) who are having the device removed after the development of a solid fusion mass.

When used as a posterior, non-cervical, non-pedicle screw fixation system, the TSRH® Spinal System is intended for the following indications: (1) degenerative disc discase (as defined by back pain of discogenic origin with degeneration of the disc confirmed by patient history and radiographic studies), (2) spinal stenosis, (3) spondylolisthesis, (4) spinal deformities (i.e., scoliosis, kyphosis, and/or lordosis), (5) fracture, (6) pseudarthrosis, (7) tumor resection, and/or (8) failed previous fusion.

When used as an anterolateral thoracic/lumbar system, the TSRH® Spinal System is intended for the following indications: (1) degenerative disc disease (as defined by back pain of discogenic origin with degeneration of the disc confirmed by patient history and radiographic studies), (2) spinal stenosis, (3) spondylolisthesis, (4) spinal deformities (i.e., scoliosis, kyphosis, and/or lordosis), (5) fracture, (6) pseudarthrosis, (7) tumor resection, and/or (8) failed previous fusion.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K014076: Modification to TSRH Spinal System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K014076

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026